According to the World Health Organization (WHO), chronic obstructive pulmonary disease (COPD) is the third leading cause of ...

Pharmaceutical titan Merck & Co. Inc. has announced a landmark $10 billion acquisition of Verona Pharma plc, underscoring its ...

If your allergy symptoms—sneezing, itchy eyes, or nasal congestion—continue to be a problem even after using medication, you ...

A grant from the Melissa Andrews Trust has funded a crucial software update for the Pulmonary Function Test machine at ...

Researchers at Stanford University have developed a new tool that can compute the “biological age” of human organs by ...

McDonald discusses her groundbreaking path in interventional pulmonology, overcoming barriers with early lung cancer ...

Synchrony Medical announced that it received FDA 510 (k) clearance for its LibAirty airway clearance system.

Frequent consumption of a common drug that acts on the nervous system and treats a range of ailments may lead to faster ...

Dupilumab reduces COPD exacerbations and Type 2 inflammation biomarkers, with strongest benefit in patients with high ...

MRK's $10B buyout of VRNA brings in Ohtuvayre, a unique COPD therapy set to bolster its cardio-pulmonary portfolio.

“This is my home, and now I’ve got to leave it and start over,” Hedley said this week as she packed up her final boxes prior ...

This figure includes 111 residents in Scotland who will see their existing PIP claims transition to Adult Disability Payment ...